Podcasts Health & Fitness Medicine NEJM Interviews Dr. Ameet Sarpatwari on state bills that aim to reduce drug spending by requiring companies to disclose R&D costs.

Dr. Ameet Sarpatwari on state bills that aim to reduce drug spending by requiring companies to disclose R&D costs.

Published: June 15, 2016, 3:01 p.m.

b'Dr. Ameet Sarpatwari is an epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women\\u2019s Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Sarpatwari, J. Avorn, and A.S. Kesselheim. State Initiatives to Control Medication Costs \\u2014 Can Transparency Legislation Help? N Engl J Med 2016;374:2301-4.'